Literature DB >> 11789554

Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery.

A S Salinas-Sánchez1, I Hernández-Millán, J G Lorenzo-Romero, M Segura-Martin, C Fernández-Olano, J A Virseda-Rodriguez.   

Abstract

OBJECTIVES: To assess the quality of life (QoL) of patients on the waiting list for benign prostatic hypertrophy (BPH) surgery and the relationship between prostate symptoms and QoL.
MATERIALS AND METHODS: Our study included 189 BPH patients on the waiting list for surgery, during the period from January to December 1999. A survey was conducted to obtain information on sociodemographic characteristics, associated illnesses, prostate symptoms based on the International Prostate Symptoms Score (I-PSS), and QoL based on the 36-item Short Form Health Survey (SF-36). Moreover, the case history, prostate volume measured by ultrasound, and uroflowmetry results were considered. Descriptive, bivariate and multivariate analyses were conducted based on the scores recorded on the SF-36 scales and the other variables.
RESULTS: The mean age was 68.8 +/- 6.9 SD. A total of 70.4% of the subjects had other chronic illnesses, 54.1% had severe symptoms (I-PSS > 19), and 69.8% reported that they were extremely dissatisfied with their symptoms. A total of 29.6% of the patients had urethral catheters. The SF-36 scale with the highest scores was social functioning (79.9, 95% CI: 76.5-83.4), whereas the lowest scores referred to role-physical (58.2, 95% CI: 52.3-64.1). Patients with more severe symptoms assigned lower scores to the physical functioning, vitality, social functioning, mental health, role-emotional and mental component summary (MCS) scales. Irritative symptoms were associated with lower vitality, social functioning, mental health and MCS. Patients with urethral catheters recorded lower scores on the physical functioning and role-physical scales.
CONCLUSIONS: The QoL of BPH patients on the waiting list for surgery is poorer than that of the general population of the same age. The increased severity of prostate symptoms, particularly the irritative symptoms, leads to a poorer QoL in terms of nearly all aspects of QoL. However, this correlation was not observed for prostate volume nor uroflowmetry data.

Entities:  

Mesh:

Year:  2001        PMID: 11789554     DOI: 10.1023/a:1013004602682

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

1.  [Acute urine retention: a public health problem].

Authors:  A Gelabert Mas
Journal:  Rev Clin Esp       Date:  1999-04       Impact factor: 1.556

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 3.  Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions.

Authors:  W M Garraway; R S Kirby
Journal:  Urology       Date:  1994-11       Impact factor: 2.649

4.  [Population reference values of the Spanish version of the Health Questionnaire SF-36].

Authors:  J Alonso; E Regidor; G Barrio; L Prieto; C Rodríguez; L de la Fuente
Journal:  Med Clin (Barc)       Date:  1998-10-10       Impact factor: 1.725

Review 5.  Social/economic status and disease.

Authors:  M G Marmot; M Kogevinas; M A Elston
Journal:  Annu Rev Public Health       Date:  1987       Impact factor: 21.981

6.  Socioeconomic inequalities in health. No easy solution.

Authors:  N E Adler; W T Boyce; M A Chesney; S Folkman; S L Syme
Journal:  JAMA       Date:  1993 Jun 23-30       Impact factor: 56.272

Review 7.  Benign prostatic hyperplasia: natural evolution versus medical treatment.

Authors:  F C Da Silva
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

8.  Patient-perceived health status before and up to 12 months after transurethral resection of the prostate for benign prostatic hypertrophy.

Authors:  H A Doll; N A Black; A B Flood; K McPherson
Journal:  Br J Urol       Date:  1993-03

9.  Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.

Authors:  W M Garraway; E B Russell; R J Lee; G N Collins; G B McKelvie; M Hehir; A C Rogers; R J Simpson
Journal:  Br J Gen Pract       Date:  1993-08       Impact factor: 5.386

10.  Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients.

Authors:  L M Eri; K J Tveter
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

View more
  6 in total

1.  How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?

Authors:  J Haltbakk; B R Hanestad; S Hunskaar
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

2.  High resolution analysis of wait times and factors affecting surgical expediency.

Authors:  Eric Cole; Wilma Hopman; Jun Kawakami
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

3.  IPSS "bother question" score predicts health-related quality of life better than total IPSS score.

Authors:  Florin V Hopland-Nechita; John R Andersen; Christian Beisland
Journal:  World J Urol       Date:  2022-01-09       Impact factor: 4.226

4.  Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia.

Authors:  Negin Hadi; Alireza Aminsharifi; Ali Sadeghi; Ali Tourchi
Journal:  Qual Life Res       Date:  2012-09-05       Impact factor: 4.147

5.  Severity of Lower Urinary Tract Symptoms among Middle Aged and Elderly Nigerian Men: Impact on Quality of Life.

Authors:  Patrick Temi Adegun; Philip Babatunde Adebayo; Peter Olufemi Areo
Journal:  Adv Urol       Date:  2016-06-19

6.  Amelioration of Benign Prostatic Hyperplasia by Costunolide and Dehydrocostus Lactone in Wistar Rats.

Authors:  Dohyun Choi; Jiyeon Kim; Jinho An; Seonhwa Hong; Youngcheon Song; Hyunseok Kong
Journal:  World J Mens Health       Date:  2019-09-23       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.